cancer

Politics John Wilkerson

STAT Plus: House subcommittee forays into fixing drug shortages

Business Jessica Bartlett — Boston Globe

STAT Plus: Dana-Farber, in break with Brigham and Women’s, will build new cancer center with Beth Israel

Politics John Wilkerson

STAT Plus: Civica Rx considers moving into chemo drugs as shortages worsen

Politics Sarah Owermohle and Angus Chen

STAT Plus: What to make of Biden’s latest Cancer Moonshot efforts

Politics John Wilkerson

STAT Plus: White House touts efforts to stem cancer drug shortages

Biotech Allison DeAngelis

STAT Plus: Nick Leschly departs Bluebird Bio spinout amid restructuring, layoffs

Hospitals Bob Herman

STAT Plus: Lawsuit raises antitrust and kickback allegations around cancer patient referrals

The Pharmalot View Ed Silverman

STAT Plus: Why the drug industry’s opaque warnings on price negotiations fall short

First Opinion Peter B. Bach

What a viral study criticizing cancer screening gets very, very wrong

Pharma Jason Mast

STAT Plus: AstraZeneca CEO Pascal Soriot proposes a novel fix to the drug pricing law’s alleged cancer problem

Biotech Elizabeth Cooney

STAT Plus: Cancer care appears brighter as off-the-shelf CAR-T advances

Health Angus Chen

Robert Winn: Without ‘high-touch’ strategies, cancer’s breakthroughs will increase disparities

In the Lab Jason Mast

STAT Plus: Carl June unveils a plan for a ‘universal CAR-T’

On Target Angus Chen and Bree Iskandar

STAT Plus: KRAS, the ideal cancer drug target that became ‘undruggable,’ takes on a new glow

Politics Damian Garde and Sarah Owermohle

STAT Plus: Drugmakers already bet big on mRNA for cancer. Why is Biden going in, too?

In the Lab Megan Molteni

STAT Plus: The first complete sequence of Y chromosome offers chance to solve longstanding genetic mysteries

Biotech Jason Mast

STAT Plus: An accidental data release by Roche boosts some hopes for anti-TIGIT cancer immunotherapies

Health Simar Bajaj

Why so few get screened for lung cancer, the deadliest cancer in the U.S.

Health Annalisa Merelli

Why drug shortages are having an outsize impact on ovarian cancer patients

Health Angus Chen

Radiation, a mainstay of cancer treatment, begins a fade-out

Matt's Take Matthew Herper

STAT Plus: From drug shortages to high prices, U.S. system’s shortcomings have deep roots

Pharmalot Ed Silverman

STAT Plus: More hospital pharmacists are rationing drugs due to increasing shortages

Politics John Wilkerson

STAT Plus: White House drug shortages task force MIA with lawmakers while Congress works on fixes

In the Lab Angus Chen

STAT Plus: A yogurt drink instead of a colonoscopy? Study uses engineered bacteria to detect cancer

Politics Rachel Cohrs

STAT Plus: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform

Health Simar Bajaj

Pandemic slowed cancer diagnoses, but late-stage cancers came back with a vengeance

Biotech Angus Chen and Matthew Herper

STAT Plus: Study proposing microbiome-based cancer diagnostic comes under fire

Exclusive John Wilkerson

STAT Plus: White House drug shortage task force held rare in-person meeting with industry

First Opinion Helen W. Boucher and Kevin Outterson

Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff